These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 28946813

  • 1. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M, Pinson S, Guillaud-Bataille M, Gimenez-Roqueplo AP, Carrie A, Barbu V, Pigny P, Bezieau S, Rey JM, Delvincourt C, Giraud S, Veyrat-Durebex C, Saulnier P, Bouzamondo N, Chabbert M, Blin J, Mohamed A, Romanet P, Borson-Chazot F, Rohmer V, Barlier A, Mirebeau-Prunier D.
    Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
    [Abstract] [Full Text] [Related]

  • 2. Role of RET genetic variants in MEN2-associated pheochromocytoma.
    Siqueira DR, Ceolin L, Ferreira CV, Romitti M, Maia SC, Maciel LM, Maia AL.
    Eur J Endocrinol; 2014 Jun; 170(6):821-8. PubMed ID: 24616415
    [Abstract] [Full Text] [Related]

  • 3. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF, Martins JM, do Vale S, Dias T, Silveira C, da Silva IR, Carmo-Fonseca M.
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [Abstract] [Full Text] [Related]

  • 4. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
    Qi XP, Zhao JQ, Fang XD, Lian BJ, Li F, Wang HH, Cao ZL, Zheng WH, Cao J, Chen Y.
    BMC Cancer; 2021 Apr 07; 21(1):369. PubMed ID: 33827484
    [Abstract] [Full Text] [Related]

  • 5. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR, Thomas BC, Richards ML, Zhang J, Morris JC.
    Thyroid; 2013 Dec 07; 23(12):1547-52. PubMed ID: 23461807
    [Abstract] [Full Text] [Related]

  • 6. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.
    Machens A, Frank-Raue K, Lorenz K, Rondot S, Raue F, Dralle H.
    Clin Endocrinol (Oxf); 2012 May 07; 76(5):691-7. PubMed ID: 22111543
    [Abstract] [Full Text] [Related]

  • 7. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.
    Figlioli G, Landi S, Romei C, Elisei R, Gemignani F.
    Mutat Res; 2013 May 07; 752(1):36-44. PubMed ID: 23059849
    [Abstract] [Full Text] [Related]

  • 8. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.
    Imai T, Uchino S, Okamoto T, Suzuki S, Kosugi S, Kikumori T, Sakurai A, MEN Consortium of Japan.
    Eur J Endocrinol; 2013 May 07; 168(5):683-7. PubMed ID: 23416954
    [Abstract] [Full Text] [Related]

  • 9. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.
    Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF, Cote G, Waguespack SG, Habra MA, Jimenez C.
    J Clin Endocrinol Metab; 2013 Nov 07; 98(11):E1813-9. PubMed ID: 24030942
    [Abstract] [Full Text] [Related]

  • 10. Rare RET Variant p.D707E in a Chinese Pedigree with Hereditary Medullary Thyroid Carcinoma.
    Zhang L, Li X, Li Q, Ge S, Chen M, Huang S, Chen B, Li P, Teng B, Xu J, Zhao S, Qi F, Zhang Y.
    Pathobiology; 2017 Nov 07; 84(3):152-160. PubMed ID: 27798940
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
    Baumgartner-Parzer SM, Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhäusl W, Vierhapper H.
    J Clin Endocrinol Metab; 2005 Nov 07; 90(11):6232-6. PubMed ID: 16118333
    [Abstract] [Full Text] [Related]

  • 12. Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.
    Gursoy A, Erdogan MF, Erdogan G.
    J Endocrinol Invest; 2006 Nov 07; 29(10):858-62. PubMed ID: 17185892
    [Abstract] [Full Text] [Related]

  • 13. Modifying impact of RET gene haplotypes on medullary thyroid carcinoma clinical course.
    Kaczmarek-Ryś M, Ziemnicka K, Pławski A, Budny B, Michalak M, Hryhorowicz S, Hoppe-Gołębiewska J, Boruń P, Gołąb M, Czetwertyńska M, Sromek M, Szalata M, Ruchała M, Słomski R.
    Endocr Relat Cancer; 2018 Apr 07; 25(4):421-436. PubMed ID: 29386230
    [Abstract] [Full Text] [Related]

  • 14. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP.
    Endocr Relat Cancer; 2008 Dec 07; 15(4):1035-41. PubMed ID: 18794325
    [Abstract] [Full Text] [Related]

  • 15. The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.
    Colombo C, Minna E, Rizzetti MG, Romeo P, Lecis D, Persani L, Mondellini P, Pierotti MA, Greco A, Fugazzola L, Borrello MG.
    Orphanet J Rare Dis; 2015 Mar 01; 10():25. PubMed ID: 25887804
    [Abstract] [Full Text] [Related]

  • 16. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
    Ospina NS, Maraka S, Donegan D, Morris JC.
    Thyroid; 2017 Oct 01; 27(10):1332-1334. PubMed ID: 28747092
    [Abstract] [Full Text] [Related]

  • 17. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL.
    Endocr Relat Cancer; 2010 Dec 01; 17(4):953-63. PubMed ID: 20801952
    [Abstract] [Full Text] [Related]

  • 18. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.
    Khan MS, Pandith AA, Iqbal M, Naykoo NA, Khan SH, Rather TA, Mudassar S.
    J Cell Biochem; 2015 Aug 01; 116(8):1712-8. PubMed ID: 25736215
    [Abstract] [Full Text] [Related]

  • 19. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
    Jung KY, Kim SM, Kim MJ, Cho SW, Kim BW, Lee YS, Jeong JJ, Nam KH, Chung WY, Lee KE, Chung EJ, Kim HJ, Park DJ, Sung MW, Park CS, Cho BY, Park YJ, Chang HS.
    Surgery; 2018 Aug 01; 164(2):312-318. PubMed ID: 29779869
    [Abstract] [Full Text] [Related]

  • 20. Multiple endocrine neoplasia type 2.
    Lodish M.
    Front Horm Res; 2013 Aug 01; 41():16-29. PubMed ID: 23652668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.